Brief: IX Biopharma Secures Israel Patent For Waferix Drug Delivery Technology
21/09/2020 02:20
Sept 21 (Reuters) - IX Biopharma Ltd IXBI.SI :
* SECURES ISRAEL PATENT FOR WAFERIX DRUG DELIVERY TECHNOLOGY
* PATENT WILL EXPIRE ON OCT 11, 2033 AND WILL PROVIDE IP
PROTECTION FOR CO'S WAFERIX DELIVERY TECHNOLOGY PLATFORM IN
ISRAEL
Source text for Eikon: ID:nSNZ9nQ3XM
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: Ix Biopharma Confirms Orion Not Yet Obtained Licence From Nevada State Board Of Pharmacy
Brief: Ix Biopharma Says U.S. Govt Opens Emergency Pathway, Clears Path For Wafermine Application For EUA
Brief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine